drugset / Trial / NCT06624072
A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate two different formulations of nerandomilast and the effect of food on the pharmacokinetics of the new formulation following oral administration.
Timeline
- Start
- 2024-10-15
- Primary completion
- 2024-11-22
- Completion
- 2024-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nerandomilast | Small molecule | 1 mg | Oral |
| Subject | Nerandomilast | Small molecule | 18 mg | Oral |
Indications
No indication recorded.